Scientific voyage of discovery
Research undertaken to understand ancient record of algal blooms
Showing 1121 - 1140 of 1965 results
Research undertaken to understand ancient record of algal blooms
ANSTO researchers contribute to study which finds evidence of Aboriginal occupation 65,000 years ago in Northern Australia.
As a result of the successful optimisation testwork, Peak Resources has commissioned ANSTO Minerals to operate the pilot plant to validate the optimised “Alkali Roast” process flowsheet that has been selected by Peak for the Bankable Feasibility Study. The study is expected to be completed by early 2017.
Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.
ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.
Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.
In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.
ANSTO is celebrating the official opening of HIFAR, Australia’s first nuclear reactor, sixty-five years ago.
ANSTO groundwater experts have collaborated with the NSW Department of Planning, Industry and Environment on a comprehensive survey of groundwater resources in the state.
A large team of international researchers have used synchrotron techniques to understand how key proteins contribute to the virulence of the rabies virus, sometimes called the “zombie virus.”
Research reveals that strong westerly winds weaken the Southern Ocean’s ability to store carbon and thereby contribute to faster accumulation of carbon dioxide in the atmosphere
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.